Pathophysiological consequences and benefits of HFE mutations: 20 years of research
Mutations in the HFE (hemochromatosis) gene cause hereditary hemochromatosis, an iron overload disorder that is hallmarked by excessive accumulation of iron in parenchymal organs. The HFE mutation p.Cys282Tyr is pathologically most relevant and occurs in the Caucasian population with a carrier frequ...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
March 24, 2017
|
| In: |
Haematologica
Year: 2017, Volume: 102, Issue: 5, Pages: 809-817 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2016.160432 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2016.160432 Verlag, Volltext: http://www.haematologica.org/content/102/5/809 
|
| Author Notes: | Ina Hollerer, André Bachmann and Martina U. Muckenthaler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1580321313 | ||
| 003 | DE-627 | ||
| 005 | 20220814231206.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180823s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2016.160432 |2 doi | |
| 035 | |a (DE-627)1580321313 | ||
| 035 | |a (DE-576)510321313 | ||
| 035 | |a (DE-599)BSZ510321313 | ||
| 035 | |a (OCoLC)1341017541 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hollerer, Ina |e VerfasserIn |0 (DE-588)1073996921 |0 (DE-627)83012067X |0 (DE-576)43551069X |4 aut | |
| 245 | 1 | 0 | |a Pathophysiological consequences and benefits of HFE mutations |b 20 years of research |c Ina Hollerer, André Bachmann and Martina U. Muckenthaler |
| 264 | 1 | |c March 24, 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.08.2018 | ||
| 520 | |a Mutations in the HFE (hemochromatosis) gene cause hereditary hemochromatosis, an iron overload disorder that is hallmarked by excessive accumulation of iron in parenchymal organs. The HFE mutation p.Cys282Tyr is pathologically most relevant and occurs in the Caucasian population with a carrier frequency of up to 1 in 8 in specific European regions. Despite this high prevalence, the mutation causes a clinically relevant phenotype only in a minority of cases. In this review, we summarize historical facts and recent research findings about hereditary hemochromatosis, and outline the pathological consequences of the associated gene defects. In addition, we discuss potential advantages of HFE mutations in asymptomatic carriers. | ||
| 700 | 1 | |a Bachmann, André |d 1948-2017 |e VerfasserIn |0 (DE-588)1165245086 |0 (DE-627)1029370370 |0 (DE-576)510321429 |4 aut | |
| 700 | 1 | |a Muckenthaler, Martina |e VerfasserIn |0 (DE-588)1046124595 |0 (DE-627)775766496 |0 (DE-576)173146813 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d Pavia : Ferrata Storti Foundation, 2014 |g 102(2017), 5, Seite 809-817 |h Online-Ressource |w (DE-627)814204899 |w (DE-600)2805244-4 |w (DE-576)424051125 |x 1592-8721 |7 nnas |a Pathophysiological consequences and benefits of HFE mutations 20 years of research |
| 773 | 1 | 8 | |g volume:102 |g year:2017 |g number:5 |g pages:809-817 |g extent:9 |a Pathophysiological consequences and benefits of HFE mutations 20 years of research |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3324/haematol.2016.160432 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.haematologica.org/content/102/5/809 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180823 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1046124595 |a Muckenthaler, Martina |m 1046124595:Muckenthaler, Martina |d 50000 |d 910000 |d 910500 |e 50000PM1046124595 |e 910000PM1046124595 |e 910500PM1046124595 |k 0/50000/ |k 0/910000/ |k 1/910000/910500/ |p 3 |y j | ||
| 998 | |g 1073996921 |a Hollerer, Ina |m 1073996921:Hollerer, Ina |d 50000 |d 910000 |d 910500 |e 50000PH1073996921 |e 910000PH1073996921 |e 910500PH1073996921 |k 0/50000/ |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1580321313 |e 3022998732 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 23.08.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1580321313","person":[{"role":"aut","display":"Hollerer, Ina","roleDisplay":"VerfasserIn","given":"Ina","family":"Hollerer"},{"display":"Bachmann, André","roleDisplay":"VerfasserIn","role":"aut","family":"Bachmann","given":"André"},{"roleDisplay":"VerfasserIn","display":"Muckenthaler, Martina","role":"aut","family":"Muckenthaler","given":"Martina"}],"title":[{"subtitle":"20 years of research","title":"Pathophysiological consequences and benefits of HFE mutations","title_sort":"Pathophysiological consequences and benefits of HFE mutations"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"title":[{"title":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title_sort":"Haematologica"}],"part":{"year":"2017","pages":"809-817","issue":"5","volume":"102","text":"102(2017), 5, Seite 809-817","extent":"9"},"titleAlt":[{"title":"journal of the European Hematology Association"}],"pubHistory":["99.2014 -"],"language":["eng"],"recId":"814204899","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Pathophysiological consequences and benefits of HFE mutations 20 years of researchHaematologica","note":["Gesehen am 27.05.2022"],"id":{"eki":["814204899"],"zdb":["2805244-4"],"issn":["1592-8721"]},"origin":[{"publisherPlace":"Pavia","dateIssuedDisp":"2014-","publisher":"Ferrata Storti Foundation","dateIssuedKey":"2014"}],"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Ina Hollerer, André Bachmann and Martina U. Muckenthaler"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"March 24, 2017"}],"id":{"doi":["10.3324/haematol.2016.160432"],"eki":["1580321313"]}} | ||
| SRT | |a HOLLERERINPATHOPHYSI2420 | ||